<DOC>
<DOCNO>EP-0647623</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Intermediates for the preparation of vitamin A and carotenoids and process for their preparation
</INVENTION-TITLE>
<CLASSIFICATIONS>C07C4720	B01J3116	B01J3124	C07C6996	C07C4900	C07C40300	C07C6900	C07C49217	C07C49796	C07C47228	C07C4721	C07C49683	C07C4565	C07B6100	C07C4567	C07C49213	C07C4554	C07C4720	C07C40314	C07C4500	C07C49203	C07B6100	C07C40300	C07C47232	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07C	B01J	B01J	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07B	C07C	C07C	C07C	C07C	C07C	C07C	C07C	C07B	C07C	C07C	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07C47	B01J31	B01J31	C07C69	C07C49	C07C403	C07C69	C07C49	C07C49	C07C47	C07C47	C07C49	C07C45	C07B61	C07C45	C07C49	C07C45	C07C47	C07C403	C07C45	C07C49	C07B61	C07C403	C07C47	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The present invention relates to new intermediates in the preparation of vitamin A and carotenoids corresponding to the following formula (I): 
<
IMAGE
>
 as well as to their process of preparation and to their use.t
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Intermediates for the preparation of 
vitamin A and carotenoids, characterized in that they 

correspond to the following formula (I): 

 
in which 


n is equal to 1 or 2 
R
1
, R
2
 and R
3
, each independently represent 
hydrogen, an alkyl unit containing 1 to 4 carbon atoms, 

an alkenyl unit containing 2 to 10 carbon atoms or an 
aryl, cycloalkyl or cycloalkenyl unit, each alkyl and/or 

alkenyl unit possibly being linear or branched, two 
groups possibly forming together an alkylidene unit 

containing from 2 to 12 carbon atoms, 
when R
1
, R
2
, and R
6
 represent a methyl group R
4
, 
R
5
, R
7
 and R
8
 represent hydrogen and n is 1, R
3
 may 
represent a trimethylsilyl group, 
R
4
, R
5
, R
6
, R
7
 and R
8
, each independently represent 
hydrogen, an alkyl unit containing 1 to 4 carbon atoms or 

an alkenyl unit containing 2 to 10 carbon atoms, each 
alkyl or alkenyl unit being linear, branched or cyclic, 

or an aryl unit containing 6 to 10 carbon atoms; two 
groups may together form an alkylidene unit containing 2 

to 10 carbon atoms. 
Intermediates according to claim 1,  
 

characterized in that R
4
, R
5
, R
7
 and R
8
 represent hydrogen 
and R
6
 represents a methyl group. 
Intermediates according to claims 1 and 2, 
characterized in that R
1
 represents the following unit: 

 
R
2
 represents a methyl group and R
3
 represents hydrogen. 
Process for the preparation of the 
intermediates of formula (I), characterized in that an 

intermediate of the following formula (II): 

 
is reacted with a catalyst based on a transition metal 

and possibly a ligand, in an aprotic solvent. 
Process according to claim 4, 
characterized in that the metal is chosen from the metals 

of colas VIII, I
B
 and II
B
 of the Periodic 
Classification. 
Process according to claim 4, 
characterized in that the metal is chosen from nickel and 

palladium. 
Process according to claim 4, 
characterized in that the ligand is a phosphine. 
Process according to claim 4, 
characterized in that the amount of catalyst used ranges 

between 1 and 20 mol% relative to the derivative of 
formula (II). 
Process for the preparation of retinal, 
characterized in that the derivative of f
ormula (I) in  
 

which R
1
 represents the group 

 
R
2
 and R
6
 
represent a methyl group and R
3
, R
4
, R
5
, R
6
 and R
7
 
represent hydrogen is treated with hydrobromic acid. 
Process for the preparation of 
dehydrocitral, characterized in that the derivative of 

formula (I) in which R
1
, R
2
 and R
6
 represent a methyl 
group and R
3
, R
4
, R
5
 and R
7
 represent hydrogen is treated 
with potassium carbonate. 
Process for the preparation of 
dehydrofernesal, characterized in that the derivative of 

formula (I) in which R
1
 represents the unit 

 
R
2
 and 
R
6
 represent a methyl group and R
3
, R
4
, R
5
 and R
7
 
represent hydrogen is treated with hydrobromic acid. 
</CLAIMS>
</TEXT>
</DOC>
